Current adjuvant treatment modalities for gastric cancer: From history to the future.

Kilic, Leyla; Ordu, Cetin; Yildiz, Ibrahim; Sen, Fatma; Keskin, Serkan; Ciftci, Rumeysa; Pilanci, Kezban Nur

Kilic, Leyla; Ordu, Cetin; Yildiz, Ibrahim; Sen, Fatma; Keskin, Serkan; Ciftci, Rumeysa; Pilanci, Kezban Nur.

Affiliation

Kilic L; Leyla Kilic, Department of Medical Oncology, Acibadem University Hospital, Istanbul 34394, Turkey.
Ordu C; Leyla Kilic, Department of Medical Oncology, Acibadem University Hospital, Istanbul 34394, Turkey.
Yildiz I; Leyla Kilic, Department of Medical Oncology, Acibadem University Hospital, Istanbul 34394, Turkey.
Sen F; Leyla Kilic, Department of Medical Oncology, Acibadem University Hospital, Istanbul 34394, Turkey.
Keskin S; Leyla Kilic, Department of Medical Oncology, Acibadem University Hospital, Istanbul 34394, Turkey.
Ciftci R; Leyla Kilic, Department of Medical Oncology, Acibadem University Hospital, Istanbul 34394, Turkey.
Pilanci KN; Leyla Kilic, Department of Medical Oncology, Acibadem University Hospital, Istanbul 34394, Turkey.

World J Gastrointest Oncol ; 8(5): 439-49, 2016 May 15.

Article de En | MEDLINE | ID: mdl-27190583

Mots clés

Adjuvant chemoradiotherapy; Biomarker; Gastric cancer; Lymph nodes

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Guideline / Prognostic_studies Langue: En Journal: World J Gastrointest Oncol Année: 2016 Type de document: Article Pays d'affiliation: Turquie Pays de publication: Chine

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google